Market Overview

Benzinga's Top Upgrades, Downgrades For December 22, 2016

Share:

Top Upgrades

  • Analysts at Summit Redstone Partners upgraded Micron Technology, Inc. (NASDAQ: MU) from Sell to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
  • Baird upgraded AMETEK, Inc. (NYSE: AME) from Neutral to Outperform. AMETEK shares fell 0.34 percent to close at $49.30 on Wednesday.
  • Citigroup upgraded Merus NV (NASDAQ: MRUS) from Neutral to Buy. Merus shares gained 0.40 percent to $20.30 in pre-market trading.
  • FBR Capital upgraded Sunoco LP (NYSE: SUN) from Market Perform to Outperform. Sunoco shares rose 6.32 percent to close at $23.54 on Wednesday.
  • Analysts at Mizuho upgraded Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) from Neutral to Buy. Sucampo Pharmaceuticals shares rose 0.78 percent to $12.95 in pre-market trading.
  • Needham & Company upgraded Micron Technology (NASDAQ: MU) from Underperform to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
  • Analysts at Baird upgraded National Instruments Corp (NASDAQ: NATI) from Neutral to Outperform. National Instruments shares fell 0.46 percent to close at $30.06 on Wednesday.


Top Downgrades

  • SunTrust Robinson Humphrey downgraded Procter & Gamble Co (NYSE: PG) from Buy to Hold. Procter & Gamble shares fell 0.50 percent to $83.86 in pre-market trading.
  • Analysts at Wells Fargo downgraded Swift Transportation Co (NYSE: SWFT) from Outperform to Market Perform. Swift Transportation shares fell 0.49 percent to close at $24.48 on Wednesday.
  • BMO Capital downgraded Greif, Inc. (NYSE: GEF) from Market Perform to Underperform. Greif shares fell 0.57 percent to close at $53.81 on Wednesday.
  • Raymond James downgraded Bed Bath & Beyond Inc. (NASDAQ: BBBY) from Strong Buy to Market Perform. Bed Bath & Beyond shares fell 4.39 percent to $43.56 in pre-market trading.
  • Analysts at B. Riley downgraded Stage Stores Inc (NYSE: SSI) from Neutral to Sell. Stage Stores shares fell 0.56 percent to close at $5.31 on Wednesday.
  • Stifel Nicolaus downgraded Red Hat Inc (NYSE: RHT) from Buy to Hold. Red Hat shares fell 12.06 percent to $70.17 in pre-market trading.
  • Analysts at Canaccord Genuity downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Hold. Finish Line shares fell 2.67 percent to $20.44 in pre-market trading.
  • Pacific Crest downgraded InvenSense Inc (NYSE: INVN) from Overweight to Sector Weight. InvenSense shares fell 0.08 percent to $12.74 in pre-market trading.
  • B. Riley downgraded Zumiez Inc. (NASDAQ: ZUMZ) from Buy to Neutral. Zumiez shares fell 2.41 percent to $22.25 in pre-market trading.


Top Initiations

 

  • Analysts at BTIG Research initiated coverage on CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) with a Buy rating. The price target for CoLucid Pharmaceuticals is set to $58. CoLucid Pharmaceuticals shares closed at $36.15 on Wednesday.
  • Analysts at JP Morgan initiated coverage on Sarepta Therapeutics Inc (NASDAQ: SRPT) with an Overweight rating. The price target for Sarepta Therapeutics is set to $40. Sarepta Therapeutics shares closed at $29.49 on Wednesday.
  • Analysts at Drexel Hamilton initiated coverage on Power Integrations Inc (NASDAQ: POWI) with a Buy rating. Power Integrations shares closed at $67.65 on Wednesday.
  • Analysts at BMO Capital initiated coverage on Healthcare Realty Trust Inc (NYSE: HR) with a Market Perform rating. The price target for Healthcare Realty Trust is set to $31. Healthcare Realty Trust shares closed at $29.39 on Wednesday.
  • Analysts at Raymond James initiated coverage on Flexion Therapeutics Inc (NASDAQ: FLXN) with a Strong Buy rating. Flexion Therapeutics shares closed at $18.18 on Wednesday.
  • Analysts at Guggenheim initiated coverage of Akamai Technologies, Inc. (NASDAQ: AKAM) with a Buy rating. The price target for Akamai Technologies is set to $75. Akamai Technologies shares closed at $67.87 on Wednesday.
  • Analysts at Piper Jaffray initiated coverage on Microsoft Corporation (NASDAQ: MSFT) with an Overweight rating. The price target for Microsoft is set to $80. Microsoft shares closed at $63.54 on Wednesday.
  • Jefferies initiated coverage on Radware Ltd. (NASDAQ: RDWR) with a Buy rating. The price target for Radware is set to $18.50. Radware shares closed at $14.31 on Wednesday.
  • Aegis Capital initiated coverage on Wynn Resorts, Limited (NASDAQ: WYNN) with a Neutral rating. The price target for Wynn Resorts is set to $87. Wynn Resorts shares closed at $89.27 on Wednesday
  • Leerink Swann initiated coverage on Cardiome Pharma Corp (NASDAQ: CRME) with an Outperform rating. Cardiome Pharma shares closed at $2.70 on Wednesday.

Latest Ratings for AME

DateFirmActionFromTo
Dec 2019MaintainsOverweight
Nov 2019Initiates Coverage OnBuy
Nov 2019MaintainsOverweight

View More Analyst Ratings for AME
View the Latest Analyst Ratings

Posted-In: Benzinga's Top Upgrades Downgrades InitiationsUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (AKAM + AME)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AMRXRaymond JamesDowngrades
MDStifelUpgrades33.0
CATStandpoint ResearchDowngrades
LULUPiperJaffrayMaintains245.0
LULUWells FargoMaintains260.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

U.S. Dollar Index Little Lower, FHFA House Prices Edge Up

The Sell-Side Reaction To Nike's Q2